Patents
Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127)
05/2004
05/26/2004EP1420802A1 Increased solubility flavanolignan preparations
05/26/2004EP1420779A2 Process for isolating phenolic compounds
05/26/2004EP1420777A2 Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof, and methods of using same
05/26/2004EP1124815B1 Method for producing luteolin and luteolin derivatives
05/26/2004CN1151144C Benzopyans and benzothiopyrans as RAR selective retinoid agonists
05/26/2004CN1151143C Methods for purifying proanthocyanidin oligomers
05/26/2004CN1151142C Technical method of extracting rutin
05/26/2004CN1151141C Process for preparing tolterodine
05/25/2004US6740756 Fluorescent lanthanide chelates
05/25/2004US6740676 Treating diseases controlled by or responsive to retinoic acid
05/25/2004CA2109237C A taste modifier and a method of modifying taste
05/25/2004CA2029419C Nmda-blocking pharmaceutical compositions
05/21/2004WO2004041961A1 Photochromic compositions and light transmissible articles
05/21/2004WO2004041805A1 NEW PROCESS FOR THE PREPARATION OF RACEMIC ([2S[2R*[R[R*]]]] and ([2R[2S*[S[S*]]]]-(±)- α,α' -[imino-bis(methylene)]bis[6-fluoro­chroman-2-methanol] AND ITS PURE [2S[2R*[R[R*]&
05/21/2004WO2004041804A2 Technical process for isolating homoeriodictyol
05/21/2004WO2004041256A2 Safe chemical uncouplers for the treatment of obesity
05/21/2004WO2004041161A2 Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity
05/21/2004CA2502174A1 Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity
05/20/2004US20040097734 Aryl- and heteroarylcarbonylpiperazines and their use for the treatment of benign and malignant oncoses
05/20/2004US20040097733 Bicyclic aromatic or heteroaromatic-amine compounds; Regulators of cell proliferation and differentiation; useful for treating skin related diseases; retinoid antagonist or retinoid inverse agonist-like biological activity
05/20/2004US20040097581 Substituted 5-oxo-5, 6, 7, 8-tetrahydro-4h-1-benzopyrans
05/20/2004US20040097580 For therapy and prophylaxis of diseases or disorders induced by promotion of lipid peroxidation or accumulation of oxidized products
05/20/2004US20040097431 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
05/20/2004US20040097430 Methods of making and using theaflavin, theaflavin-3-gallate, theaflavin-3'-gallate and theaflavin 3,3'-digallate and mixtures thereof
05/20/2004US20040096397 Sulfonated diarylrhodamine dyes
05/20/2004US20040094753 Photochromic compound exhibits absorption bands in two wavelength regions of 440 to 500 nm and 570 to 630 nm.
05/19/2004EP1419163A1 Tricyclic imidazopyridines
05/19/2004EP1220849B1 Bicyclic compounds composition and method for stabilizing the same
05/19/2004EP1000051B1 Carbamyloxy compounds which inhibit leukocyte adhesion mediated by vla-4
05/19/2004DE60003103T2 Substituierte dimere Verbindungen Verfahren zu deren Herstellung und deren pharmazeutischen Zusammensetzungen Substituted dimeric compounds process for their preparation and their pharmaceutical compositions
05/19/2004CN1496999A Solid phase synthesing method of aldehyde, ketonic, oxime amine and isohydroximic acid compound
05/19/2004CN1150189C Benzopyranone and benzodihydropyranon derivatives as integrin inhibitors
05/19/2004CN1150183C New heterocylic tertiary amines, process for their preparation and pharmaceutical compositions containing them
05/19/2004CN1150182C Preparation process of esterified benzodihydropyran compound
05/19/2004CN1150181C Substituted benzopyran analogs for treatment of inflammation
05/19/2004CN1150180C Diarylbenzopyran derivatives as cycloosygenase-2 inhibitors
05/18/2004US6737239 Nucleic acid sequence detection employing probes comprising non-nucleosidic coumarin derivatives as polynucleotide-crosslinking agents
05/18/2004US6737142 Optical data store comprising an axially substituted cobalt phthalocyanine in the light-writeable information layer
05/18/2004US6736998 Indenonaphthopyran compounds when exposed to light radiation containing ultraviolet rays exhibit a reversible change in color; lenses and ophthalmic lenses
05/13/2004WO2004039793A1 Aminated isoflavonoid derivatives and uses thereof
05/13/2004WO2004039386A1 Method for isolation of sylimarin from sylibum marianum seeds
05/13/2004WO2004024709A3 Xanthenyl cubane analogs with activity at the metabotropic glutamate receptors
05/13/2004WO2004009576A3 Manufacture of isoflavones
05/13/2004WO2002055013A8 Therapeutic chromone compounds
05/13/2004WO2002048102A3 Isocoumarin inhibiting production of amyloid peptide, preparation, compositions containing same and uses
05/13/2004US20040092738 Hydrolysis of 3,7-dialkanoyloxyphenoxazine derivative; measuring fluorescence
05/13/2004US20040092579 Central nervous system diosrders; catalytic hydrogenation
05/13/2004US20040092578 Inhibition of the cystic fibrosis transmembrane conductance regulator chloride channel
05/13/2004US20040092572 Benzopyranone compounds, compositions thereof, and methods of treatment therewith
05/13/2004US20040092556 Aids therapy
05/13/2004US20040092506 Administering estrogen antagonist; skin disorders; wrinkle resistance; antiarthritic agents; anticancer agents; wound healing agents
05/13/2004US20040091433 Chromene derivative
05/13/2004CA2504653A1 Aminated isoflavonoid derivatives and uses thereof
05/12/2004EP1418177A1 Novel pseudolaric acid-b derivatives, their preparation and pharmaceutical compositions
05/12/2004EP1417196A1 Dna-pk inhibitors
05/12/2004EP1417169A2 Selective estrogen receptor modulators
05/12/2004EP1208095B1 Dibenzopyrans as glucocorticoid receptor antagonists for treatment of diabetes
05/12/2004CN1496407A Flavonoid compound and process for producing the same
05/12/2004CN1495260A Method for purifying raw anthocyanidin oligomer
05/12/2004CN1495178A Purification method of raw anthocyanidin oligomer
05/06/2004WO2004037246A1 Nerve fiber regeneration accelerator
05/06/2004WO2004037193A2 Chromones and chromone derivatives and uses thereof
05/06/2004WO2004037020A1 Soy isoflavone concentrate process and product
05/06/2004WO2003040096A3 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives
05/06/2004US20040087798 Novel amide compounds
05/06/2004US20040087663 Viricides
05/06/2004US20040087640 Administering by mouth; cyclooxygenase inhibitor; controlling particle size
05/06/2004US20040087610 Method and composition for the treatment of cancer
05/06/2004US20040087586 Chromone compound; also viricide, antiinflammatory agents
05/06/2004US20040087575 Therapeutic chromone compounds
05/06/2004US20040086746 Organic light emitting diode and organic luminescent materials thereof
05/06/2004US20040084867 Individualization of therapy with anticoagulants
05/06/2004EP1415995A2 Photocleavable agents and conjugates for the detection and isolation of biomolecules
05/06/2004EP1414937A1 Hops extracts, method for the production and use
05/06/2004EP1414775A2 Novel bicyclic and tricyclic cannabinoids
05/06/2004EP1124986B1 Nitrocoumarins for detecting all micro-organisms
05/06/2004CA2502975A1 Chromones and chromone derivatives and uses thereof
05/05/2004CN1494545A 非核苷逆转录酶抑制剂 Non-nucleoside reverse transcriptase inhibitors
05/05/2004CN1493571A 木犀草素金属盐及其制备方法和用途 Luteolin and its preparation method and use salt
05/05/2004CN1148365C Process for concentrating catechin solution
05/05/2004CN1148197C Ginkgo biloba flavonoid extract which is terpene-free and/or has high flavonoid heteroside content
05/04/2004US6730783 Reacting aminoguanidine with carbonyl compound to form amidinohydrazone; reduction; reacting with alkoxyamine; guanidinylation; anticoagulants
05/04/2004US6730669 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
05/04/2004US6730519 Method of preparing delta-9-tetrahydrocannabinol
04/2004
04/29/2004WO2004035556A1 Substituted piperazines, (1,4) diaszepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists
04/29/2004WO2004035002A2 Benzopyranone compounds, compositions thereof, and methods for treating or preventing cancer
04/29/2004WO2004013079A8 Ketocampholenic acid derivatives and their use in fragrance and flavour applications
04/29/2004WO2003009807A3 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods
04/29/2004WO2002078626A3 Therapeutic combinations for cardiovascular and inflammatory indications
04/29/2004US20040082648 Fermentation of a culture product; drug, antiseptics; antibiotic resistant infections
04/29/2004US20040082638 Compounds, compositions and methods
04/29/2004US20040082591 Psychological disorders; antidepressants; anxiolytic agents; eating disorders; sleep disorders; gastrointestinal disorders; cardiovascular disorders
04/29/2004US20040081715 Cholesterol reducing confectionery comprising a cocoa procyanidin monomer and/or oligomer and a sterol and/or stanol based cholesterol lowering agent
04/29/2004CA2502249A1 Substituted piperazines, (1,4) diaszepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists
04/29/2004CA2502064A1 Benzopyranone compounds, compositions thereof, and methods for treating or preventing cancer
04/28/2004EP1413569A1 Bicyclic cyclopropane derivatives capable of polymerisation and their use in the preparation of dental materials
04/28/2004EP1412376A2 Compositions and methods for labeling oligonucleotides
04/28/2004EP1412345A1 Method for treating a product stream containing vitamin e acetate
04/28/2004EP1412344A1 Iodobenzopyran-4-one derivatives having fungicidal activity
04/28/2004EP1412343A1 New compounds, which are potent inhibitors of na+/ca2+ exchange mechanism and are useful in the treatment of arrhythmias